Management of Individuals at Higher Risk for Jaundice
All newborns at higher risk for severe jaundice require predischarge bilirubin measurement (TSB or TcB) plotted on an hour-specific nomogram, combined with systematic assessment of clinical risk factors, followed by structured early follow-up within 24-96 hours based on discharge timing. 1
Risk Stratification Framework
Major Risk Factors (Highest Priority)
- Predischarge TSB or TcB level in the high-risk zone on the Bhutani nomogram is the strongest predictor of severe hyperbilirubinemia 1
- Jaundice observed in the first 24 hours indicates likely hemolytic disease and requires immediate TSB/TcB measurement 1
- Blood group incompatibility (ABO or Rh) with positive direct Coombs test, or other hemolytic diseases including G6PD deficiency—notably, G6PD deficiency caused hyperbilirubinemia in 31.5% of infants who developed kernicterus in one series 1
- Gestational age 35-36 weeks carries significantly elevated risk 1
- Previous sibling who received phototherapy 1
- Cephalohematoma or significant bruising from birth trauma 1
- Exclusive breastfeeding with poor intake and excessive weight loss 1
- East Asian race 1
Minor Risk Factors
- Predischarge TSB/TcB in high-intermediate zone 1
- Gestational age 37-38 weeks 1
- Jaundice observed before discharge 1
- Previous sibling with jaundice 1
- Macrosomic infant of diabetic mother 1
- Maternal age ≥25 years 1
- Male gender 1
Prenatal and Immediate Postnatal Management
Maternal Testing
- All pregnant women must have ABO and Rh(D) blood typing with antibody screen 1
- If mother is Rh-negative or blood type unknown, obtain cord blood for infant blood type, Rh(D) type, and direct antibody test (Coombs) 1
- If maternal blood is group O, Rh-positive, cord blood testing is optional but requires rigorous surveillance and follow-up protocols 1
Routine Monitoring Protocol
- Assess all infants for jaundice every 8-12 hours minimum by blanching skin with digital pressure 1
- Visual estimation alone is unreliable, particularly in darkly pigmented infants—when in doubt, measure TSB or TcB 1
Predischarge Risk Assessment (Critical)
Bilirubin Measurement Strategy
- Measure predischarge TSB or TcB on every newborn before discharge, particularly those leaving before 72 hours of age 1
- Plot the value on the hour-specific Bhutani nomogram to determine risk zone (low, low-intermediate, high-intermediate, or high) 1
- TSB can be obtained simultaneously with routine metabolic screening to avoid additional blood draws 1
- Infants with predischarge TSB in the low-risk zone have very low likelihood of developing severe hyperbilirubinemia 1
Laboratory Evaluation for High-Risk Infants
If jaundice appears in first 24 hours or appears excessive:
- Measure TSB/TcB immediately 1
- Blood type and Coombs test if not obtained from cord blood 1
- Complete blood count with smear 1
- Consider reticulocyte count and G6PD testing 1
If TSB rising rapidly or approaching phototherapy levels:
- Reticulocyte count, G6PD, albumin 1
- End-tidal CO (ETCOc) if available 1
- Repeat TSB in 4-24 hours depending on level and infant age 1
Structured Follow-Up Protocol
Timing Based on Discharge Age
Mandatory follow-up schedule: 1
- Discharged before 24 hours: See by 72 hours of age
- Discharged 24-47.9 hours: See by 96 hours of age
- Discharged 48-72 hours: See by 120 hours of age
Follow-Up Assessment Components
- Weight and percentage change from birth weight 1
- Adequacy of intake, particularly breastfeeding frequency and technique 1, 2
- Voiding and stooling patterns (number of wet diapers and bowel movements) 1, 2
- Visual assessment for jaundice with low threshold for TSB/TcB measurement 1
- If any doubt exists about jaundice severity, measure bilirubin—do not rely on visual estimation 1
Treatment Thresholds for High-Risk Infants
Immediate Phototherapy Indications
- Initiate intensive phototherapy immediately for TcB >340 μmol/L (>20 mg/dL) to prevent bilirubin encephalopathy 2
- Use special blue fluorescent tubes or LED lights delivering irradiance >30 μW/cm²/nm 2
- Position lights 10-15 cm above infant 2
- Maximize skin exposure (remove all clothing except diaper) with eye protection 2
Monitoring During Treatment
- Assess hydration status; consider IV fluids if dehydration present or oral intake inadequate 2
- Repeat TSB within 4-24 hours depending on initial level and response 2
- Plot results on hour-specific nomogram to assess treatment response 2
Special Populations Requiring Enhanced Surveillance
Infants with Hemolytic Disease
- G6PD deficiency occurs in 11-13% of African Americans and was implicated in 31.5% of kernicterus cases in one series 1
- These infants require closer monitoring with lower treatment thresholds 3
Late Preterm Infants (35-36 weeks)
- Significantly higher risk for severe hyperbilirubinemia 1, 2
- Require more intensive monitoring and earlier follow-up 2
Breastfed Infants with Poor Intake
- Ensure 8-12 feedings per 24 hours 2
- Monitor for excessive weight loss (>7-10% of birth weight) 1
- Breastfeeding technique assessment is essential 2
Prolonged Jaundice Management (Beyond 3 Weeks)
All infants jaundiced at or beyond 3 weeks require: 1, 4
- Total and direct (conjugated) bilirubin measurement to identify cholestasis 1, 4
- Verification of newborn thyroid and galactosemia screening results 1, 4
- Urinalysis and urine culture if direct bilirubin elevated 1, 4
- Evaluation for sepsis if indicated by clinical findings 1
Parent Education Requirements
Provide written and verbal discharge information including: 1
- Explanation of jaundice and its significance
- Instructions on how to monitor for jaundice at home
- Clear guidance on when to seek immediate medical attention
- Importance of scheduled follow-up appointments
Critical Pitfalls to Avoid
- Never rely on visual estimation alone—always measure bilirubin when jaundice severity is uncertain, especially in darkly pigmented infants 1
- Do not discharge high-risk infants before 72 hours without explicit follow-up plan 1
- Always interpret bilirubin levels according to infant's age in hours, not days 1
- Do not miss conjugated hyperbilirubinemia—measure direct bilirubin in prolonged jaundice to avoid delayed diagnosis of biliary atresia 1, 4